Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-12-05

Clinical Trial Update: Evolution of Bone Mineral Density (BMD) in Patients With Lymphoma Undergoing Chemotherapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing changes in bone mineral density in lymphoma patients undergoing chemotherapy has been withdrawn. The study explored osteoporosi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Lymphoma, Osteoporosis | Phase 4 | Status: WITHDRAWN